Stem cell therapy for critical limb ischaemia - a review.
about
Improvement in Blood Supply After "Heparin-Dextran" Therapy in Patients of Buerger's Disease with Critical Limb Ischemia.Development of a surrogate potency assay to determine the angiogenic activity of Stempeucel®, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell productEfficacy, safety and influencing factors of intra-calf muscular injection of bone marrow mononuclear cells in the treatment of type 2 diabetes mellitus-induced lower extremity vascular disease.
P2860
Stem cell therapy for critical limb ischaemia - a review.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Stem cell therapy for critical limb ischaemia - a review.
@ast
Stem cell therapy for critical limb ischaemia - a review.
@en
type
label
Stem cell therapy for critical limb ischaemia - a review.
@ast
Stem cell therapy for critical limb ischaemia - a review.
@en
prefLabel
Stem cell therapy for critical limb ischaemia - a review.
@ast
Stem cell therapy for critical limb ischaemia - a review.
@en
P2860
P1476
Stem cell therapy for critical limb ischaemia - a review.
@en
P2093
Anjan Kumar Das
P2860
P304
P356
10.1007/S12262-009-0059-7
P577
2009-08-01T00:00:00Z